COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success

Overview of attention for article published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, May 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,915 followers.

COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success https://t.co/sld0kPZLHL

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.